Class IITerminatedD-1056-2019
Drug recall · April 3, 2019
Combigan recall
Why: cGMP Deviations
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% 5 mL bottles, Rx only, Allergan, Inc. Irvine, CA 92612 U.S.A. NDC 0023-9211-05
- Lots / codes
Lot#: 99946 Exp. January 16, 2021
- Quantity
- 72 bottles
- Company
- Allergan Sales, LLC, Waco, TX
- Distribution
- TN only
- Initiated
- March 19, 2019 · Voluntary: Firm initiated
- Classified
- March 22, 2019
- Reported
- April 3, 2019
- Ended
- April 29, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Combigan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.